This review provides an overview of antiplatelet drugs, their mechanisms of action, and their recommended usage in cardiovascular diseases.
Answers are grounded in this paper and cite their sources.
Updates clinicians on antiplatelet options; leaves open needs for prospective trials on personalization.
Platelets play an important role both in normal hemostasis and in pathological thrombus formation. Several large-scale clinical studies have proved that the inhibition of platelet aggregation results in a significant decrease in mortality and morbidity of ischemic atherothrombotic events, thus antiplatelet therapy became a key pharmacological method in prevention and treatment of such cardiovascular, cerebrovascular and peripheral arterial diseases. The present paper aims to give a brief overview of the most important antiplatelet drugs, their mechanism of action and their recommended usage in cardiovascular diseases. We also discuss possible methods to monitor the effectiveness of therapy and possible causes of therapeutic failure.
No takes yet. Share an insight, caveat, or question.
Papp et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: